The U.S. Congress is actively debating a new healthcare data privacy bill, poised to introduce substantial 20% fines by mid-2025, significantly impacting the financial landscape and operational strategies of healthcare providers across the nation.
The FDA's recent approval of three groundbreaking AI-powered medical devices for the U.S. market in Q1 2025 marks a significant leap in healthcare technology, promising enhanced diagnostic accuracy and transformative patient care.